## Background: The prostate specific antigen (psa) has been characterized as a specific prostate marker. recent studies have indicated the existence of a psa of nonprostatic origin detected in lactating women and breast tumors. ## Methods: We have evaluated the presence of psa by an ultrasensitiv
Detection of nonprostatic PSA in serum and nonserum samples from women
โ Scribed by Xavier Filella; Rafael Molina; Juan Alcover; Pablo Carretero; Antonio Manuel Ballesta
- Publisher
- John Wiley and Sons
- Year
- 1996
- Tongue
- French
- Weight
- 342 KB
- Volume
- 68
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
โฆ Synopsis
Prostate-specific antigen (PSA) has been characterized as a specific prostate marker, although recent studies have suggested the existence of PSA of nonprostatic sources. We have assessed the presence of PSA by an ultrasensitive assa~y in 276 serum and nonserum samples from women. Our data show the presence of PSA in 90% of nonsewm samples, including milk secretions, breast cysts, amniotic fluids and broncho-alveolar washings. We have also detected its presence in 58% of the sera tested, although it only exceeded 0. I kg/l in 6 of the cases. We conclude that PSA can no longer be considered a specific prostate tissue marker; since the concentrations detected in women's serum are ultralow, this finding appears to interfere minimally with its value as a tumoral marker.
๐ SIMILAR VOLUMES
The current assays for serum prostate specific antigen (PSA) have failed to produce the same PSA values on the same specimens because of problems with antibody specificity and calibrator preparation. To eliminate these problems, we proposed to replace the current serum PSA assay with an assay specif
## Abstract We compared the use of serum and filter paper blood spots as specimen sources for the detection of measlesโ and rubellaโspecific IgM and IgG. We collected capillary blood into microtainer tubes and onto filter paper spots from 60 children and 60 healthy adults. The blood was collected f
## BACKGROUND. This study was undertaken to assess the correlation between CA 125 elevation, a past history of cancer, and future risk of a diagnosis of cancer among asymptomatic postmenopausal women. ## METHODS. The subjects consisted of a study group of 771 women with elevated CA125 (ี30 U/mL)